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INTRODUCTION: 
Zika virus is an emerging arthropod borne virus 
(arbovirus) transmitted by Aedes (Stegomyia) 
mosquitoes. The virus belongs to the genus Flavivirus, 
family Flaviviridae, and is closely related to other Flavi 
viruses such as dengue, yellow fever and West Nile 
viruses. Zika Virus is an RNA virus containing 10,794 
nucleotides encoding 3,419 amino acids. Zika Virus was 
first isolated from a rhesus monkey in the Zika Forest of 
Uganda, in 1947.
1
  Zika Virus was first isolated from 
humans in 1968, in Nigeria. Zika Virus has been 
considered as emergent since 2007.In 2007, an outbreak 
of Zika Virus occurred on YAP, the western state of 
Micronesia. There was 49 conformed and 59 probable 
cases of Zika identified. Roughly 73% of the 11,241 
population was infected according to the CDC. In 
November 2013, an outbreak occurred in the islands of 
Western Polynesia, including Tahiti. As of January 13, 
2014 the number of confirmed Zika cases was 361, 
while the number of suspected cases was over 35,000. In 
February 2014, New Caledonia reported 49 cases, 30 
were cases imported from French Polynesia, some cases 
were confirmed to be autochthonous.
2 
Clinical Manifestations: 
The first well-documented report of human Zika Virus 
disease was in 1964 when Simpson described his own 
occupationally acquired Zika illness at age 28. It began 
with mild headache. Next day, a maculopapular rash 
covered his face, neck, trunk, and upper arms, and 
spread to his palms and soles. Transient fever, malaise, 
and back pain developed. 
 
By the evening of the second day of illness he was a 
febrile, the rash was fading, and he felt better. By day 
three, he felt well and had only the rash, which 
disappeared over the next 2 days. Zika Virus was 
isolated from serum collected while he was febrile.
3
 In 
1973, laboratory-acquired Zika Virus illness in a man 
was reported with acute onset of fever, headache, and 
joint pain but no rash which was isolated from serum 
collected on the first day of symptoms; the man’s illness 
resolved in 1 week. Of the 7 Zika Virus case-patients in 
Indonesia, all had fever, but they were detected by 
hospital-based surveillance for febrile illness.
4
 Other 
manifestations included anorexia, diarrhea, constipation, 
abdominal pain, and dizziness. The outbreak on Yap 
Island was characterized by rash, conjunctivitis, and 
ABSTRACT 
Zika virus, a mosquito borne flavivirus transmitted primarily by Aedes aegypti mosquitoes is a pathogen affecting humans. 
These vectors also transmit dengue and chikungunya virus and are found throughout much of the world, including parts of 
the United States. An estimated 80% of persons infected with Zika virus are asymptomatic. Microcephaly is the greater risk 
for the infant born from the Zika Virus infected pregnant mother. This virus also causes neurological syndromes. Zika virus 
disease can often be diagnosed by performing reverse transcriptase-polymerase chain reaction (RT-PCR) on serum. 
Keywords: Zika Virus, Pregnancy, Microcephaly, Aedes aegypti mosquito, Brazil. 
 
Parajuli et al                                      Journal of Drug Delivery & Therapeutics. 2016; 6(2):52-56 53 
© 2011-16, JDDT. All Rights Reserved                                     ISSN: 2250-1177                                   CODEN (USA): JDDTAO 
arthralgia. Other less frequent manifestations included 
myalgia, headache, retroorbital pain, edema, and 
vomiting.
5
 
Symptoms of Zika Virus: 
Zika Virus infection in humans symptoms ranges from 
asymptomatic to influenza like symptoms such as fever, 
headache, arthralgia, myalgia, malaise, anorexia, rash, 
asthenia, retro-orbital eye pain, oedema, 
lymphadenopathy, and diarrhoea. Symptoms usually 
begin 3-7 days after a person is bitten by an infected 
mosquito and last several days to a week. The illness is 
usually mild, and severe, disease requiring 
hospitalization is uncommon. There is no specific 
treatment for Zika virus disease. The only treatment 
option available is the provision of supportive care 
including rest, fluids, and use of analgesics and 
antipyretics.
6  
 
 
Figure A: lymphadenopathy; B: maculopapular rash; C: periarticular swelling. 
 
Zika virus related deaths: 
In 28 November 2015, the Brazil MoH has notified 3 
deaths associated with Zika virus infection. The fatal 
cases are 2 adults and one newborn. The first fatal case 
is a male adult with no neurological disorders, with 
history of lupus erythematosus, chronic use of 
corticosteroid drugs, rheumatoid arthritis, and 
alcoholism. He was admitted as a suspected dengue 
case, but the final laboratory diagnosis by RTP-PCR 
technique was Zika virus infection.It was detected by 
RT-PCR in the blood and organ samples (brain, liver, 
spleen, kidney, lung, and heart). Additionally, Zika virus 
was identified through partial sequencing of the virus.  
The second fatal case is a 16 year old female from the 
state of Pará. She had no neurological disorder, and was 
admitted to the hospital as a suspected dengue case. The 
onset of her symptoms (headache, nausea, and 
petechiae) was on 29 September 2015 and she died in 
late October. Zika virus infection was confirmed by 
RTp-PCR.
7
 
Transmission of Zika virus: 
There are 18 countries and territories in the Americas 
that have confirmed autochthonous circulation of Zika 
virus in 2015 and 2016: Brazil, Barbados, Colombia, 
Ecuador, El Salvador, French Guiana, Guatemala, 
Guyana, Haiti, Honduras, Martinique, Mexico, Panama, 
Paraguay, Puerto Rico, Saint Martin, Suriname, and 
Venezuela. 
8
 
Zika Virus and Microcephaly: 
In October 2015, the Brazil International Health 
Regulations (IHR) notified the detection of an unusual 
increase in microcephaly cases in public and private 
healthcare facilities in Pernambuco state, Northeast 
Brazil. As of epidemiological week of 2016, there were 
3,530 microcephaly cases recorded, including 46 deaths, 
in 20 states and the Federal District. Between 2010 and 
2014, an average of 163 (SD 16.9) microcephaly cases 
was recorded nationwide per year. 
9
 In January 2016, 
ophthalmological findings were reported in three 
children with microcephaly and cerebral calcifications 
detected by CT scans and presumable intrauterine Zika 
Virus infection. The three infants had unilateral ocular 
findings involving the macular region and loss of foveal 
reflex. In one child well defined macular neuroretinal 
atrophy was detected.On 13 January 2016, the Brazil 
Ministry of Health reported the detection of Zika virus 
genome, through the RT-PCR technique in four cases of 
congenital malformation in the state of Rio Grande do 
Norte. The cases correspond to two miscarriages and 
two full-term newborns (37 and 42 weeks respectively) 
who died in the first 24 hours of life. Tissue samples 
from both newborns were also positive for Zika virus by 
immune histochemistry.
9
 This adds to the evidence 
reported in the Epidemiological Alert of 1 December 
2015 with respect to the detection of Zika virus genome 
through RT-PCR technique in the amniotic fluid of two 
pregnant women in Paraiba, whose fetus presented with 
microcephaly according to the ultrasound. 
10
 Zika Virus 
transmitted by Aedes mosquitoes, was identified in 
northeast Brazil, an area where dengue virus was also 
circulating. By September, reports of an increase in the 
number of infants born with microcephaly in Zika virus-
affected areas began to emerge, and Zika virus RNA was 
identified in the amniotic fluid of two women whose 
fetuses had been found to have microcephaly by prenatal 
ultrasound. The Brazil Ministry of Health (MoH) 
established a task force to investigate the possible 
association of microcephaly with Zika virus infection 
during pregnancy and a registry for incident 
microcephaly cases (head circumference ≥2 SD below 
the mean for sex and gestational age at birth) and 
pregnancy outcomes among women suspected to have 
had Zika virus infection during pregnancy. Among a 
cohort of 35 infants with microcephaly born during 
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August–October 2015 in eight of Brazil’s 26 states and 
reported to the registry, the mothers of all 35 had lived 
in or visited Zika virus-affected areas during pregnancy, 
25 (71%) infants had severe microcephaly (head 
circumference >3 SD below the mean for sex and 
gestational age), 17 (49%) had at least one neurologic 
abnormality, and among 27 infants who had 
neuroimaging studies, all had abnormalities. Tests for 
other congenital infections were negative. All infants 
had a lumbar puncture as part of the evaluation and 
cerebrospinal fluid (CSF) samples were sent to a 
reference laboratory in Brazil for Zika virus testing; 
results are not yet available. Further studies are needed 
to confirm the association of microcephaly with Zika 
virus infection during pregnancy and to understand any 
other adverse pregnancy outcomes associated with Zika 
virus infection.CDC recently tested samples from two 
pregnancies that ended in miscarriage and from two 
infants with microcephaly who died shortly after birth. 
All four cases were from Brazil and were positive for 
Zika virus infection, indicating that the infants had 
become infected during pregnancy. Zika virus was 
present in the brain of the full term infants, and genetic 
sequence analyses show that the virus in all four cases 
was the same as the Zika virus strain currently 
circulating in Brazil. All four mothers reported having 
experienced a febrile rash illness during their 
pregnancies.
11 
 Zika Virus and neurological syndromes: 
During the Zika virus outbreak in French Polynesia,74 
patients had presented neurological syndromes or auto-
immune syndromes after the manifestation of symptoms 
consistent with Zika virus infection. Of these, 42 were 
classified as Guillain-Barré Syndrome (GBS) out of 
which 24 (57%) were male, and 37 (88%) had signs and 
symptoms consistent with Zika virus infection.
8
 In July 
2015, Brazil reported the detection of patients with 
neurological syndromes who had recent history of Zika 
virus infection in the state of Bahia. There were 76 
patients with neurological syndromes identified, of 
which 42 (55%) were confirmed as GBS. Among the 
confirmed GBS, 26 (62%) had a history of symptoms 
consistent with Zika virus infection.  In addition, on 25 
November 2015, the AMRC of the Oswaldo Cruz 
Foundation reported that Zika Virus infection was found 
in 10 of the 224 suspected dengue patients whose 
samples were analyzed for Zika virus infection. Seven of 
the 10 samples analyzed corresponded to patients with 
neurological syndrome. In January 2016, El Salvador 
reported the detection of an unusual increase of GBS 
.On average, El Salvador records14 cases of GBS per 
month (169 cases per year), however, between 1 
December 2015 and 6 January 2016 there were 46 GBS 
recorded, two of which died. 25 (54%) were male and 35 
(76%) were over 30 years old. All were hospitalized and 
treated with immunoglobulin. Of the deceased patients, 
one had a history of multiple underlying chronic 
diseases. In 22 patients whose information was 
available, 12 (54%) had febrile rash illness between 7 
and 15 days prior to the onset of GBS.  
Currently, similar situations are being investigated in 
other countries of the Americas. These findings are 
consistent with a temporal and spatial link between Zika 
virus circulation and the increase of GBS. Although the 
etiopathogenesis and associated risk factors have not yet 
been well established, Member States should implement 
surveillance systems to detect unusual increases in cases 
and prepare health services for care of patients with 
neurological conditions. Zika virus can cause other 
neurological syndromes such as meningitis, 
meningoencephalitis and myelitis. 
Sexual Transmission: 
Zika Virus transmission by sexual intercourse has been 
suggested by Foy et al., who described a patient who 
was infected in southeastern Senegal in 2008. After 
returning to his home in Colorado, United States, he 
experienced common symptoms of Zika Virus infection 
and symptoms of prostatitis. Four days later, he 
observed signs of hematospermia, and on the same day, 
his wife had symptoms of Zika Virus infection. 
Transmission by semen was suggested as the wife of the 
patient had not traveled out of the United States during 
the previous year and had sexual intercourse with him 1 
day after he returned home. Zika Virus infection of the 
patient and his wife was confirmed by serologic testing, 
but the presence of Zika Virus in the semen of the pa-
tient was not investigated.
12
 
CDC Interim Guidelines: 
CDC has developed interim guidelines for health care 
providers in the United States caring for pregnant 
women during a Zika virus outbreak. These guidelines 
include recommendations for pregnant women 
considering travel to an area with Zika virus 
transmission and recommendations for screening, 
testing, and management of pregnant returning travelers. 
Health care providers should ask all pregnant women 
about recent travel. Pregnant women with a history of 
travel to an area with Zika virus transmission and who 
report two or more symptoms consistent with Zika virus 
disease (acute onset of fever, maculopapular rash, 
arthralgia, or conjunctivitis) during or within 2 weeks of 
travel, or who have ultrasound findings of fetal 
microcephaly or intracranial calcifications, should be 
tested for Zika virus infection in consultation with their 
state or local health department. Testing is not indicated 
for women without a travel history to an area with Zika 
virus transmission. In pregnant women with laboratory 
evidence of Zika virus infection, serial ultrasound 
examination should be considered to monitor fetal 
growth and anatomy and referral to a maternal-fetal 
medicine or infectious disease specialist with expertise 
in pregnancy management is recommended. There is no 
specific antiviral treatment for Zika virus; supportive 
care is recommended. 
13
 
Diagnosis: 
During the first week of illness, Zika virus disease can 
often be diagnosed by performing reverse transcriptase-
polymerase chain reaction (RT-PCR) on serum. 
Serology assays can also be used to detect Zika virus-
specific IgM and neutralizing antibodies, which typically 
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develop toward the end of the first week of illness. 
Plaque-reduction neutralization testing (PRNT) can be 
performed to measure virus-specific neutralizing 
antibodies to confirm primary flavivirus infections and 
differentiate from other viral illnesses. Laboratory 
evidence of maternal Zika virus infection can include 
Zika virus RNA detected by RT-PCR in any clinical 
specimen; or positive Zika virus IgM with confirmatory 
neutralizing antibody titers that are ≥4-fold higher than 
dengue virus neutralizing antibody titers in serum. 
Testing would be considered inconclusive if Zika virus 
neutralizing antibody titers are < 4-fold higher than 
dengue virus neutralizing antibody titers. 
Challenges in interpreting Zika virus testing:  
RT-PCR test may not demonstrate Zika virus RNA in a 
woman with Zika virus infection if the period of viremia 
has passed. Serum serologic testing can be performed, 
however, cross-reactivity with related flaviviruses (e.g., 
dengue and yellow fever viruses) is common. Plaque-
reduction neutralization testing (PRNT) can be 
performed to measure virus-specific neutralizing 
antibodies to Zika virus, but neutralizing antibodies may 
still yield cross-reactive results in persons who were 
previously infected with another flavivirus, such as 
dengue, or has been vaccinated against yellow fever or 
Japanese encephalitis.  
 Prevention: 
There is no specific medication and Vaccines found yet 
for the treatment of Zika Virus Infection. Treatment is 
generally supportive and can include rest, fluids, and use 
of analgesics and antipyretics. Fever should be treated 
with paracetamol and acetaminophen. Although aspirin 
and other nonsteroidal anti-inflammatory drugs are not 
typically used in pregnancy, these medications should 
specifically be avoided to reduce the risk for 
hemorrhage. Preventing mosquito bites is the only way 
to avoid becoming infected. The mosquito that spreads 
Zika is very aggressive and bites during the day and 
early evening.  
 Using insect repellent containing picaridin, oil of 
lemon eucalyptus, is safe and effective and long 
lasting protective. Pregnant & breast feeding 
women should choose an EPA-registered insect 
repellent and use it according to the product label 
after applying the sunscreen cream. 
 When weather permits, wear long-sleeved shirts and 
long pants. 
 Use air conditioning or window/door screens to 
keep mosquitoes outside. 
 Use a mosquito bed net while sleeping. 
 Help reduce the number of mosquitoes by emptying 
standing water in the surrounding. 
 
 
CONCLUSION: 
In this way after a long time span of about half a century 
later its first eruption in humans, Aedes aegypti vector of 
Zika Virus, still stretch to no end and has tremendously 
influenced health status of many people, among which 
pregnant ladies are at top most risk since fetus gets 
directly invaded leading to microcephaly along with 
other congenital complications. The present disease 
burden suggests for conduction of high scientific 
research and clinical trials promptly in order to control 
the most alarming disease pattern of the evolving global 
scenario. Although, about 80% of persons infected with 
Zika virus are assumed to be asymptomatic, In contrast, 
symptoms may include maculopapular rash, fever, 
headache, anorexia, diarrhoea, constipation, joint and 
abdominal pain, myalgia, edema, dizziness, and 
vomiting. There is a possible association between Zika 
and microcephaly (abnormally small head and brain) in 
newborns. It is suspected that women who get infected 
with Zika virus may pass the virus to the developing 
fetus if they are pregnant. However, there are many 
causes of microcephaly in babies, but evidence on   Zika 
virus infection causes microcephaly has not been 
confirmed. Thus more study is needed to understand this 
possible relationship. 
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